University of Arizona, Department of Surgery, Tucson, AZ, USA.
Clin Transplant. 2012 Jul-Aug;26(4):622-8. doi: 10.1111/j.1399-0012.2011.01579.x. Epub 2011 Dec 22.
We examined the outcomes of adult intestinal transplants (ITx); isolated ITx vs. liver-intestinal transplants (L-ITx) were compared using the UNOS database (1987-2009). Of 759 ITx transplants in 687 patients, 463 (61%) were isolated and 296 (39%) were L-ITx. Patient survival for primary isolated ITx at one, three, and five yr was 84%, 66.7%, and 54.2%; and primary L-ITx was, 67%, 53.3%, and 46% (p = 0.0005). Primary isolated ITx graft survival at one, three, and five yr was 80.7%, 57.6%, 42.8%; primary L-ITx was 64.1%, 51%, 44.1% (p = 0.0003 at one, three yr, Wilcoxon test). For retransplants (n = 72), patient and graft survival for isolated ITx (n = 41) at five yr was 40% in era 1 (1987-2000) and 16% in era 2 (p = 0.47); for retransplanted L-ITx (n = 31), it improved from 14% to 64% in era 2 (p = 0.01). Cox regression: creatinine >1.3 mg/dL and pre-transplant hospitalization were negative predictors for outcome of both; bilirubin >1.3 mg/dL was a negative predictor for isolated ITx and donor age >40 yr for L-ITx. Isolated ITx should be considered prior to liver disease for adults with intestinal failure; L-ITx is preferable for retransplantation.
我们研究了成人肠移植(ITx)的结果;使用 UNOS 数据库(1987-2009 年)比较了孤立 ITx 与肝肠联合移植(L-ITx)。在 687 例患者的 759 例 ITx 移植中,463 例(61%)为孤立型,296 例(39%)为 L-ITx。原发性孤立 ITx 的患者 1 年、3 年和 5 年生存率分别为 84%、66.7%和 54.2%;原发性 L-ITx 分别为 67%、53.3%和 46%(p = 0.0005)。原发性孤立 ITx 移植物 1 年、3 年和 5 年的存活率分别为 80.7%、57.6%和 42.8%;原发性 L-ITx 分别为 64.1%、51%和 44.1%(Wilcoxon 检验,p = 0.0003,1 年和 3 年)。对于再次移植(n = 72),孤立 ITx(n = 41)的患者和移植物 5 年生存率在 1 期(1987-2000 年)为 40%,在 2 期为 16%(p = 0.47);对于再次移植的 L-ITx(n = 31),在 2 期从 14%提高到 64%(p = 0.01)。Cox 回归:肌酐>1.3mg/dL 和移植前住院是两种结果的负预测因素;胆红素>1.3mg/dL 是孤立 ITx 的负预测因素,供体年龄>40 岁是 L-ITx 的负预测因素。对于有肠衰竭的成年人,应在肝病之前考虑孤立 ITx;对于再次移植,L-ITx 更可取。